J. Barbuto
发表
K. Pasqualoto,
M. Tavares,
A. Ferreira,
2014,
Archiv der Pharmazie.
R. Ramos,
J. Barbuto,
Cristiano Jacob de Moraes,
2013,
Clinical & developmental immunology.
R. Ramos,
J. Barbuto,
F. Laginha,
2012,
Journal of leukocyte biology.
J. Barbuto,
G. Romagnoli,
B. Zelante,
2015,
Front. Immunol..
R. Ramos,
J. Barbuto,
P. C. Bergami-Santos,
2015,
Cancer Immunology, Immunotherapy.
K. Pinello,
B. Cogliati,
T. C. da Silva,
2009,
Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
A. Buzaid,
J. Barbuto,
M. Gioso,
2008
.
E. Hersh,
R. M. Bernstein,
D. Lake,
1995,
Cancer research.
J. Barbuto,
I. K. Migliori,
M. P. Pinho,
2014,
Journal of leukocyte biology.
M. Nagai,
F. R. Nascimento,
J. Barbuto,
2019,
Mediators of inflammation.
E. Caldini,
J. Barbuto,
G. Romagnoli,
2013,
Journal of Circulating Biomarkers.
E. Hersh,
J. Barbuto,
W. J. Grimes,
2005,
Cancer Immunology, Immunotherapy.
D. Frank,
S. R. Walker,
P. Moraes-Vieira,
2015,
The Journal of Immunology.
Darwin Q. Ye,
D. Frank,
J. Yeh,
2016,
Oncotarget.
C. Rodrigues,
J. Barbuto,
Cristiano Jacob de Moraes,
2016,
Front. Immunol..
H. Ochs,
T. Torgerson,
M. Hackett,
2012,
The Journal of allergy and clinical immunology.
K. Pasqualoto,
L. Travassos,
C. Rodrigues,
2015,
Peptides.
S. Roy,
J. Orange,
A. Dzutsev,
2020,
Blood advances.
J. Barbuto,
A. B. Machado,
A. Machado,
1998,
Arquivos de neuro-psiquiatria.
R. Medzhitov,
M. Russo,
R. Ramos,
2015,
The Journal of Immunology.
J. Barbuto,
M. Mariano,
P. C. Bergami-Santos,
2004,
Life sciences.
N. Câmara,
M. Marques,
Ê. J. Bassi,
2014,
PloS one.
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy
B. Strauss,
J. Barbuto,
A. Hunger,
2017,
Oncotarget.
C. Punt,
K. Hatch,
E. Hersh,
1994,
Cancer Immunology, Immunotherapy.
Human monocytes but not dendritic cells are killed by blocking of autocrine cyclooxygenase activity.
J. Barbuto,
P. C. Bergami-Santos,
Clara M Cavalcanti,
2009,
Cellular immunology.
C. Silva,
M. Carneiro-Sampaio,
J. Barbuto,
2020,
Clinics.
F. V. Loures,
J. Barbuto,
C. Feriotti,
2013,
Infection and Immunity.
R. Ramos,
V. Rocha,
E. Rego,
2021,
Frontiers in Cell and Developmental Biology.
H. F. Carvalho,
T. M. Augusto,
J. Barbuto,
2020,
Journal of cellular physiology.
Alissa M. Weaver,
Daisuke Hoshino,
M. Cruz,
2016,
Oncotarget.
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy
B. Strauss,
J. Barbuto,
A. Hunger,
2017,
Oncotarget.
F. Sallusto,
J. Barbuto,
T. Patente,
2019,
Oncoimmunology.
Roberto Venegeroles,
J. Barbuto,
Robinson F Alvarez,
2019,
Journal of theoretical biology.
M. G. D. de Magalhães,
P. Cury,
N. D. de Araújo,
2009,
Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.
Ana Elisa Amaro Rodrigues,
C. Furuse,
P. Cury,
2008,
Brazilian oral research.
J. Köhl,
E. Reis,
L. Isaac,
2007,
Molecular immunology.
E. Reis,
L. Isaac,
J. Barbuto,
2006,
Inflammation Research.
N. Câmara,
E. Latz,
R. Curi,
2020,
Clinical science.
Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States
I. Jurisica,
N. Câmara,
H. Ochs,
2022,
bioRxiv.
N. Câmara,
M. Russo,
G. Cabral-Miranda,
2021,
Vaccines.
C. Ries,
I. Treilleux,
C. Caux,
2020,
Clinical & translational immunology.
N. Câmara,
E. Latz,
R. Curi,
2021,
Clinical science.
A. Buzaid,
K. Leite,
F. Costa,
2004,
Cancer Immunology, Immunotherapy.
Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States
I. Jurisica,
N. Câmara,
H. Ochs,
2021,
bioRxiv.
J. Barbuto,
2015,
Autopsy & case reports.
N. Câmara,
E. Latz,
A. Kowaltowski,
2017,
Scientific Reports.
L. Travassos,
R. Azevedo,
C. Figueiredo,
2020,
Frontiers in Immunology.
R. Stripecke,
A. Ferreira,
J. Barbuto,
2016,
Cytotherapy.
J. Barbuto,
G. C. M. Evangelista,
Lucas Henrique Rodrigues da Silva,
2022,
Biomedicines.
A. Buzaid,
K. Leite,
L. H. Câmara-Lopes,
2004,
Cancer Immunology, Immunotherapy.
J. Barbuto,
M. P. Pinho,
2018,
Front. Immunol..
B. Strauss,
J. Barbuto,
O. L. Cerqueira,
2020,
Frontiers in Immunology.
L. Ferreira,
S. Boscardin,
R. Ramos,
2017,
Molecular Cancer Therapeutics.
E. Reis,
L. Isaac,
J. Barbuto,
2007,
Immunobiology.
R. Rees,
F. Regnier,
A. Trautmann,
2017,
Journal of Immunotherapy for Cancer.
S. Nonogaki,
R. Chammas,
L. Morganti,
2010,
Cell transplantation.
R. Poppi,
J. Fox,
R. Minghim,
2015,
Oncotarget.
A. Longatto-Filho,
E. Baracat,
L. Villa,
2017,
Scientific Reports.
L. G. de la Torre,
M. T. Vitor,
J. Barbuto,
2016,
Journal of nanoscience and nanotechnology.
J. Barbuto,
B. E. Malucelli,
Leoni Villano Bonamin,
2002,
Neuroimmunomodulation.
L. G. de la Torre,
M. T. Vitor,
J. Barbuto,
2017,
Journal of liposome research.
M. Srougi,
A. Antunes,
M. Dall'oglio,
2006,
Sao Paulo medical journal = Revista paulista de medicina.
E. Hersh,
E. Verástegui,
J. Barbuto,
1993,
Hybridoma.
A. Longatto-Filho,
E. Baracat,
L. Villa,
2017,
Scientific Reports.
F. Soares,
J. Barbuto,
F. Haddad,
2008,
Cancer Immunology, Immunotherapy.
Darwin Q. Ye,
D. Frank,
Suhu Liu,
2016,
Oncotarget.
B. Cogliati,
T. C. da Silva,
S. L. Górniak,
2009,
Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
D. P. Frias,
J. Barbuto,
K. Yoshizaki,
2024,
Journal of applied toxicology : JAT.